Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database-Reference-Cited by-同舟云学术

Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database

Published:2021-02 Issue:2 Volume:57 Page:106252
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Lombardi Francesca,Giacomelli Andrea^ORCID,Armenia Daniele^ORCID,Lai Alessia,Dusina Alex,Bezenchek Antonia,Timelli Laura,Saladini Francesco^ORCID,Vichi Francesca,Corsi Paola,Colao Grazia,Bruzzone Bianca,Gagliardini Roberta^ORCID,Callegaro Annapaola,Castagna Antonella,Santoro Maria Mercedes^ORCID

Funder

MSD Italia

Gilead Sciences

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference34 articles.

1. Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial;Wegner;Clin Infect Dis,2004

2. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management;Wensing;J Infect Dis,2005

3. Understanding HIV-1 drug resistance;Frenkel;Ther Drug Monit,2004

4. Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure;Di Giambenedetto;AIDS Res Hum Retroviruses,2008

5. Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus;Castagna;J Antimicrob Chemother,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry;Journal of Antimicrobial Chemotherapy;2024-07-15

2. Prevalence, predictors and geospatial patterns of HIV drug resistance in South Africa: Insights from the 2017 national HIV household survey;2024-05-28

3. Prevalence of people living with multidrug‐resistant HIV and limited treatment options in Spain;HIV Medicine;2024-04-30

4. Prevalence of HIV drug resistance at antiretroviral treatment failure across regions of Russia;HIV Medicine;2024-04-07

5. Mechanism of action, resistance, interaction, pharmacokinetics, pharmacodynamics, and safety of fostemsavir;BMC Infectious Diseases;2024-02-23